Common end points after BM and PBSC collection
Variable . | Total donors (N = 453) . | BM donors (n = 313) . | PBSC donors (n = 140) . | P . | HR (95% CI) . |
---|---|---|---|---|---|
Pain (not related to G-CSF) | |||||
No | 237 (52.3%) | 118 (37.7%) | 119 (85.0%) | < .0001 | |
Yes (no analgesics) | 50 (11.0%) | 38 (12.1%) | 12 (8.6%) | ||
Yes (nonnarcotic analgesics) | 166 (36.7%) | 157 (50.2%) | 9 (6.4%) | ||
Blood allotransfusion | |||||
No | 368 (81.2%) | 229 (73.2%) | 131 (93.6%) | < .0001 | 5.3 (2.5-11.8) |
Yes | 85 (18.8%) | 84 (26.8%) | 9 (6.4%) | ||
No. of days spent in hospital after collection | |||||
0 | 118 (26.1%) | 12 (3.8%) | 106 (75.7%) | < .0001 | |
1 | 265 (58.5%) | 240 (76.7%) | 25 (17.9%) | ||
2 or more | 70 (15.4%) | 61 (19.5%) | 9 (6.4%) | ||
Iron supplementation | |||||
No | 156 (34.4%) | 70 (22.4%) | 86 (61.4%) | < .0001 | 6.9 (4.3-11.3) |
Yes | 273 (60.3%) | 232 (74.1%) | 41 (29.3%) | ||
No data | 24 (5.3%) | 11 (3.5%) | 13 (9.3%) |
Variable . | Total donors (N = 453) . | BM donors (n = 313) . | PBSC donors (n = 140) . | P . | HR (95% CI) . |
---|---|---|---|---|---|
Pain (not related to G-CSF) | |||||
No | 237 (52.3%) | 118 (37.7%) | 119 (85.0%) | < .0001 | |
Yes (no analgesics) | 50 (11.0%) | 38 (12.1%) | 12 (8.6%) | ||
Yes (nonnarcotic analgesics) | 166 (36.7%) | 157 (50.2%) | 9 (6.4%) | ||
Blood allotransfusion | |||||
No | 368 (81.2%) | 229 (73.2%) | 131 (93.6%) | < .0001 | 5.3 (2.5-11.8) |
Yes | 85 (18.8%) | 84 (26.8%) | 9 (6.4%) | ||
No. of days spent in hospital after collection | |||||
0 | 118 (26.1%) | 12 (3.8%) | 106 (75.7%) | < .0001 | |
1 | 265 (58.5%) | 240 (76.7%) | 25 (17.9%) | ||
2 or more | 70 (15.4%) | 61 (19.5%) | 9 (6.4%) | ||
Iron supplementation | |||||
No | 156 (34.4%) | 70 (22.4%) | 86 (61.4%) | < .0001 | 6.9 (4.3-11.3) |
Yes | 273 (60.3%) | 232 (74.1%) | 41 (29.3%) | ||
No data | 24 (5.3%) | 11 (3.5%) | 13 (9.3%) |